English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/49242
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients

AuthorsSanz, David J.; Acedo, Alberto ; Infante, Mar ; Durán, Mercedes ; Pérez-Cabornero, Lucía ; Miner, Cristina ; Velasco, Eladio
Issue DateMar-2010
PublisherAmerican Association for Cancer Research
CitationClinical Cancer Research 16(6): 1957-1967 (2010)
Abstract[Purpose]: Most BRCA1/2 mutations are of unknown clinical relevance. An increasing amount of evidence indicates that there can be deleterious effects through the disruption of the splicing process. We have investigated the effect of aberrant splicing of BRCA1/2 on hereditary breast/ovarian cancer (HBOC). [Experimental Design]: DNA variants were analyzed with splicing prediction programs to select putative splicing mutations. Splicing assays of 57 genetic variants were done by lymphocyte reverse transcription-PCR and/or hybrid minigenes in HeLa and nontumor breast epithelial cells. [Results]: Twenty-four BRCA1/2 variants of Spanish HBOC patients were bioinformatically preselected. Functional assays showed that 12 variants induced anomalous splicing patterns, 6 of which accounted for 58.5% of BRCA1 families. To further evaluate the defective splicing of BRCA1/2, we analyzed 31 Breast Cancer Information Core Database (BIC) and two artificial variants that were generated by mutagenesis. Sixteen variants induced different degrees of aberrant splicing. Altogether, anomalous splicing was caused by 28 BRCA1/2 variants of all types, indicating that any DNA change can disrupt pre-mRNA processing. We show that a wide range of regulatory elements can be involved, including the canonical and cryptic splice sites, the polypyrimidine tract, and splicing enhancers/silencers. Twenty mutations were predicted to truncate the BRCA proteins and/or to delete essential domains, thus supporting a role in HBOC. [Conclusions]: An important fraction of DNA variants of BRCA1/2 presents splicing aberrations that may represent a relevant disease-causing mechanism in HBOC. The identification of splicing disruptions by functional assays is a valuable tool to discriminate between benign polymorphisms and pathogenic mutations.
Description11 páginas, 3 figuras, 2 tablas.-- et al.-- El pdf del artículo es la versión post-print.
Publisher version (URL)http://dx.doi.org/10.1158/1078-0432.CCR-09-2564
URIhttp://hdl.handle.net/10261/49242
DOI10.1158/1078-0432.CCR-09-2564
ISSN1078-0432
E-ISSN1557-3265
Appears in Collections:(IBGM) Artículos
Files in This Item:
File Description SizeFormat 
A high proportion of DNA.pdf576,9 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.